Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2019

14.11.2018 | Correspondence

Nonalcoholic Fatty Liver Disease and Bone Mineral Density in Children and Adolescents: Specific Considerations for Future Studies

verfasst von: Alessandro Mantovani

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
2.
Zurück zum Zitat Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20.CrossRefPubMed Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20.CrossRefPubMed
3.
Zurück zum Zitat Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol. 2013;58:1218–1229.CrossRefPubMed Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol. 2013;58:1218–1229.CrossRefPubMed
4.
Zurück zum Zitat Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extra-hepatic diseases. Gut. 2017;66:1138–1153.CrossRefPubMed Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extra-hepatic diseases. Gut. 2017;66:1138–1153.CrossRefPubMed
5.
Zurück zum Zitat Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018;14:99–114.CrossRef Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018;14:99–114.CrossRef
6.
Zurück zum Zitat Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018;15:425–439.CrossRefPubMed Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018;15:425–439.CrossRefPubMed
7.
Zurück zum Zitat Targher G, Lonardo A, Rossini M. Nonalcoholic fatty liver disease and decreased bone mineral density: Is there a link? J Endocrinol Investig. 2015;38:817–825.CrossRef Targher G, Lonardo A, Rossini M. Nonalcoholic fatty liver disease and decreased bone mineral density: Is there a link? J Endocrinol Investig. 2015;38:817–825.CrossRef
8.
Zurück zum Zitat Upala S, Jaruvongvanich V, Wijarnpreecha K, Sanguankeo A. Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. J Bone Miner Metab. 2017;35:685–693.CrossRefPubMed Upala S, Jaruvongvanich V, Wijarnpreecha K, Sanguankeo A. Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. J Bone Miner Metab. 2017;35:685–693.CrossRefPubMed
9.
Zurück zum Zitat Pirgon O, Bilgin H, Tolu I, Odabas D. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2011;75:189–195.CrossRef Pirgon O, Bilgin H, Tolu I, Odabas D. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2011;75:189–195.CrossRef
10.
Zurück zum Zitat Pardee PE, Dunn W, Schwimmer JB. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther. 2012;35:248–254.CrossRefPubMed Pardee PE, Dunn W, Schwimmer JB. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther. 2012;35:248–254.CrossRefPubMed
11.
Zurück zum Zitat Campos RM, de Piano A, da Silva PL, et al. The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine. 2012;42:146–156.CrossRef Campos RM, de Piano A, da Silva PL, et al. The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine. 2012;42:146–156.CrossRef
12.
Zurück zum Zitat Pacifico L, Bezzi M, Lombardo CV, et al. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease. World J Gastroenterol. 2013;19:4007–4014.CrossRefPubMedPubMedCentral Pacifico L, Bezzi M, Lombardo CV, et al. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease. World J Gastroenterol. 2013;19:4007–4014.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Nobili V, Giorgio V, Liccardo D, et al. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol. 2014;170:547–553.CrossRefPubMed Nobili V, Giorgio V, Liccardo D, et al. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol. 2014;170:547–553.CrossRefPubMed
14.
Zurück zum Zitat Chang EJ, Yi DY, Yang HR. Vitamin D status and bone mineral density in obese children with nonalcoholic fatty liver disease. J Korean Med Sci. 2015;30:1821–1827.CrossRefPubMedPubMedCentral Chang EJ, Yi DY, Yang HR. Vitamin D status and bone mineral density in obese children with nonalcoholic fatty liver disease. J Korean Med Sci. 2015;30:1821–1827.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Bachrach LK. Diagnosis and treatment of pediatric osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2014;21:454–460.CrossRefPubMed Bachrach LK. Diagnosis and treatment of pediatric osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2014;21:454–460.CrossRefPubMed
18.
Zurück zum Zitat Kelley JC, Crabtree N, Zemel BS. Bone density in the obese child: clinical considerations and diagnostic challenges. Calcif Tissue Int. 2017;100:514–527.CrossRefPubMedPubMedCentral Kelley JC, Crabtree N, Zemel BS. Bone density in the obese child: clinical considerations and diagnostic challenges. Calcif Tissue Int. 2017;100:514–527.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Vandewalle S, Taes Y, Van Helvoirt M, et al. Bone size and bone strength are increased in obese male adolescents. J Clin Endocrinol Metab. 2013;98:3019–3028.CrossRefPubMed Vandewalle S, Taes Y, Van Helvoirt M, et al. Bone size and bone strength are increased in obese male adolescents. J Clin Endocrinol Metab. 2013;98:3019–3028.CrossRefPubMed
20.
Zurück zum Zitat Tothill P, Laskey MA, Orphanidou CI, van Wijk M. Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments. Br J Radiol. 1999;72:661–669.CrossRefPubMed Tothill P, Laskey MA, Orphanidou CI, van Wijk M. Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments. Br J Radiol. 1999;72:661–669.CrossRefPubMed
21.
Zurück zum Zitat Golden NH, Abrams SA. Committee on nutrition. Optimizing bone health in children and adolescents. Pediatrics. 2014;134:e1229–e1243.CrossRefPubMed Golden NH, Abrams SA. Committee on nutrition. Optimizing bone health in children and adolescents. Pediatrics. 2014;134:e1229–e1243.CrossRefPubMed
22.
Zurück zum Zitat Prentice A. Nutritional rickets around the world. J Steroid Biochem Mol Biol. 2013;136:201–206.CrossRefPubMed Prentice A. Nutritional rickets around the world. J Steroid Biochem Mol Biol. 2013;136:201–206.CrossRefPubMed
23.
Zurück zum Zitat Brown M. Skeletal muscle and bone: effect of sex steroids and aging. Adv Physiol Educ. 2008;32:120–126.CrossRefPubMed Brown M. Skeletal muscle and bone: effect of sex steroids and aging. Adv Physiol Educ. 2008;32:120–126.CrossRefPubMed
Metadaten
Titel
Nonalcoholic Fatty Liver Disease and Bone Mineral Density in Children and Adolescents: Specific Considerations for Future Studies
verfasst von
Alessandro Mantovani
Publikationsdatum
14.11.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5370-3

Weitere Artikel der Ausgabe 3/2019

Digestive Diseases and Sciences 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.